UTHR daily bearish hammer in selling resistance zoneOrder SELL UTHR NASDAQ.NMS Stop 209.45 LMT 209.45 will be automatically canceled at 20230401 01:00:00 EST
UTHR daily bearish hammer in selling resistance zone
Next report date
Report period
Q1 2024
EPS estimate
94.57MXN
Revenue estimate
10.28 BMXN
357.62MXN
16.73 BMXN
39.53 BMXN
43.37 M
About United Therapeutics Corporation
Sector
CEO
Martine A. Rothblatt
Headquarters
Silver Spring
Website
Employees (FY)
1.17 K
Founded
1996
FIGI
BBG01LKZR958
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
UTHR daily indecision candle at resistanceOrder SELL UTHR NASDAQ.NMS Stop 211.77 LMT 211.77 will be automatically canceled at 20230401 01:00:00 EST
UTHR daily indecision hammer at resistance can be nice ride into support zone.
Descending TriangleCould break either way. Any triangle can break up or down. It is a consolidation pattern
Also a H&S pattern.
The talking heads are saying Buy healthcare so be safe, or not. The players will run HC up until it will cave as well.
They usually do the same thing over and over and suck us in a long
UTHR - No ResistanceUTHR has no resistance (shown with dotted green horizontal)
A breakout should ensue and lead to further bullish increases
This is all occurring along a strong up trend line formed by the bulls
UTHR - A Reminder to let trades breathe!!!I went long UTHR on Tuesday, as per the position marked.
Its consolidating nicely after breaking out from a previous high and looked really good.
Unfortunately I messed the whole thing up!!!
I got a pretty nasty entry (got a little too trigger happy on the breakout).
My strategy as always but es
UTHR H&S top with Bear pennantFollowing up on August 22nd idea. Will today be the day UTHR tests its neckline?
Head & Shoulders Top Formation $UTHR$UTHR has built a text book classic Head & Shoulders top. It is resting near its neckline breakdown area $213.75. Consolidation above the neckline breakdown area of $215-$220 has created a bearish looking pennant formation. All in all $UTHR looks sickly, and probably headed for lower prices. If ne
Head and ShouldersPrice is on the neckline.
Earnings miss.
Entry short with a break of the neckline and a downtrend.
No recommendation.
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chroni
$UTHR #supertrend #breakout$UTHR Breakout in 1h Chart
Target 262$
Stop-Loss 236$
Risk Reward Ratio 2.7
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where UTHR is featured.
Frequently Asked Questions
The current price of UTHR is 3663.34 MXN — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange UNITED THERAPEUTICS CORP stocks are traded under the ticker UTHR.
UNITED THERAPEUTICS CORP is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
UTHR stock is 0% volatile and has beta coefficient of 0.53. Check out the list of the most volatile stocks — is UNITED THERAPEUTICS CORP there?
UTHR earnings for the last quarter are 93.78 MXN per share, whereas the estimation was 88.93 MXN resulting in a 5.45% surprise. The estimated earnings for the next quarter are 72.77 MXN per share. See more details about UNITED THERAPEUTICS CORP earnings.
UNITED THERAPEUTICS CORP revenue for the last quarter amounts to 10.62 B MXN despite the estimated figure of 10.21 B MXN. In the next quarter revenue is expected to reach 9.77 B MXN.
Yes, you can track UNITED THERAPEUTICS CORP financials in yearly and quarterly reports right on TradingView.
UTHR stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in UNITED THERAPEUTICS CORP price.
UTHR net income for the last quarter is 3.69 B MXN, while the quarter before that showed 4.66 B MXN of net income which accounts for −20.95% change. Track more UNITED THERAPEUTICS CORP financial stats to get the full picture.
Today UNITED THERAPEUTICS CORP has the market capitalization of 189.32 B, it has increased by 3.71% over the last week.
No, UTHR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, UTHR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UNITED THERAPEUTICS CORP stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 1.17 K employees. See our rating of the largest employees — is UNITED THERAPEUTICS CORP on this list?
We've gathered analysts' opinions on UNITED THERAPEUTICS CORP future price: according to them, UTHR price has a max estimate of 6259.81 MXN and a min estimate of 3054.79 MXN. Read a more detailed UNITED THERAPEUTICS CORP forecast: see what analysts think of UNITED THERAPEUTICS CORP and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UNITED THERAPEUTICS CORP EBITDA is 21.03 B MXN, and current EBITDA margin is 53.35%. See more stats in UNITED THERAPEUTICS CORP financial statements.